The usefulness of intra-aortic balloon pumping (IABP) for lung cancer patients with severe ischemic heart disease

Masato Kanzaki; Takamasa Onuki; Toyohide Ikeda; Motoki Sakuraba; Masaki Nishiuchi; Takayuki Tatebayashi; Kunihiko Oyama; Hideto Kaneyasu; Masahide Murasugi; Sumio Nitta

doi:10.2995/jacsurg.14.156

Masato Kanzaki, Takamasa Onuki, Toyohide Ikeda, Motoki Sakuraba, Masaki Nishiuchi, Takayuki Tatebayashi, Kunihiko Oyama, Hideto Kaneyasu, Masahide Murasugi, Sumio Nitta

Author information

Masato Kanzaki
Department of Surgery I, Tokyo Women's Medical University
Takamasa Onuki
Department of Surgery I, Tokyo Women's Medical University
Toyohide Ikeda
Department of Surgery I, Tokyo Women's Medical University
Motoki Sakuraba
Department of Surgery I, Tokyo Women's Medical University
Masaki Nishiuchi
Department of Surgery I, Tokyo Women's Medical University
Takayuki Tatebayashi
Department of Surgery I, Tokyo Women's Medical University
Kunihiko Oyama
Department of Surgery I, Tokyo Women's Medical University
Hideto Kaneyasu
Department of Surgery I, Tokyo Women's Medical University
Masahide Murasugi
Department of Surgery I, Tokyo Women's Medical University
Sumio Nitta
Department of Surgery I, Tokyo Women's Medical University

Keywords: primary lung cancer, ischemic heart disease, intra-aortic balloon pumping, coronary artery bypass grafting, percutaneous transluminal coronary angioplasty

JOURNAL FREE ACCESS

2000 Volume 14 Issue 2 Pages 156-161

DOI https://doi.org/10.2995/jacsurg.14.156

Details

Abstract

Surgical management of patients with concomitant resectable lung lesions and critical cardiac disease is controversial. We examined the usefulness of intra-aortic balloon pumping (IABP) for lung cancer patients with severe ischemic heart disease. They had difficulty being treated by coronary intervention. And these patients are mistimed the operation because of severe ischemic heart disease. In lung cancer patients who are surgically resected, left main trunk (LMT) disease, unstable angina and low ejection fraction (less than 30-40%) are indications for scheduled IABP. No complications were observed due to IABP in any patients of this group.rWe conclude that scheduled IABP is useful for lung cancer patients with severe ischemic heart disease.

Corresponding author